Daily Courier: Single Column

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dexcom Inc (NQ: DXCM )

70.48 -1.32 (-1.84%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dexcom Inc

< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
$100 Invested In This Stock 10 Years Ago Would Be Worth $3,000 Today
DexCom (NASDAQ:DXCM) has outperformed the market over the past 10 years by 28.51% on an annualized basis producing an average annual return of 40.1%. Currently, DexCom has a market capitalization of... 
Via Benzinga
Roku, Intel And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Good morning, trader! It's time to start off Friday with a breakdown of the biggest pre-market stock movers traders need to know about! 
Via InvestorPlace
Why Amazon Is Trading Higher By 12%: Here Are 23 Stocks Moving Premarket
Gainers Getty Images Holdings, Inc. (NYSE: GETY) rose 104.5% to $21.47 in pre-market trading. 
Via Benzinga
DexCom Shares Slip As Q2 Earnings Miss Estimates, Tightens FY22 Outlook
DexCom Inc's (NASDAQ: DXCM) reported second-quarter reve 
Via Benzinga
What 10 Analyst Ratings Have To Say About DexCom
DexCom (NASDAQ:DXCM) has observed the following analyst ratings within the last quarter: 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers 
Via Benzinga
Recap: DexCom Q2 Earnings
DexCom (NASDAQ:DXCM) reported its Q2 earnings results on Thursday, July 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings DexCom missed estimated earnings by... 
Via Benzinga
Dexcom Reports Second Quarter 2022 Financial Results
From DexCom, Inc.
Via Business Wire
Dexcom G6 Continuous Glucose Monitoring System Mobile App Now Available in Spanish
From Dexcom, Inc.
Via Business Wire
Nasdaq And 2 Other Stocks Insiders Are Selling
US gold futures traded mostly flat on Tuesday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
3 Biotech Stocks to Buy on the Dip
Biotech stocks have rebounded lately and are poised to keep surging, so it's a good time to buy biotech stocks on the dip. 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 15, 2022
  
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
  This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Here's How Much $100 Invested In DexCom 15 Years Ago Would Be Worth Today
DexCom (NASDAQ:DXCM) has outperformed the market over the past 15 years by 20.1% on an annualized basis producing an average annual return of 26.25%. Currently, DexCom has a market capitalization of... 
Via Benzinga
Dexcom Schedules Second Quarter 2022 Earnings Release and Conference Call for July 28, 2022 at 4:30 p.m. Eastern Time.
From DexCom, Inc.
Via Business Wire
Thoughts For Thursday: Which Way Through Uncertainty?
Markets are trying to maintain resistance levels generated from last week's rally, but finding the path to doing so is proving to be no easy matter. 
Via Talk Markets
Happy Birthday, iphone!
Exactly a decade and a half ago to the day, what is now the staple of the smartphone market first hit the shelves. 
Via Talk Markets
Here's How Much You Would Have Made Owning DexCom Stock In The Last 15 Years
DexCom (NASDAQ:DXCM) has outperformed the market over the past 15 years by 20.9% on an annualized basis producing an average annual return of 27.35%. Currently, DexCom has a market capitalization of... 
Via Benzinga
Comparing Fitbits To Medical Devices? This Company Says Things Aren't Even Close
The health and wellness industry focused on the well-being of the body, mind and spirit has captured the globe's attention. According to management consulting firm, Mckinsey & Co., the global wellness... 
Via Benzinga
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $16,000 Today
DexCom (NASDAQ:DXCM) has outperformed the market over the past 5 years by 64.52% on an annualized basis producing an average annual return of 74.42%. Currently, DexCom has a market capitalization of... 
Via Benzinga
Relief May Soon Be On The Way For Diabetes Sufferers Weary Of Constant Pin Pricks, According To This Company
Last year was the 100th anniversary of the discovery of insulin, which was instrumental in improving people's lives around the world. 
Via Benzinga
7 Undervalued Penny Stocks to Buy for Massive Gains
These seven undervalued penny stocks each have the potential to pay off for investors down later down the road. 
Via InvestorPlace
Here's Why These 14 Companies Did A Stock Split In 2022
A stock split's main purpose is to make a company's shares more appealing to potential investors. By raising the number of outstanding shares, it improves a company's liquidity. Stock splits do not... 
Via Benzinga
Markets Rise Amid Strength In Tech, Software
U.S. indices finished Thursday’s trading session higher. Overall tech and software sector strength as well as strong first-quarter results from Mongodb Inc (NASDAQ: MDB) lifted markets higher for the... 
Via Benzinga
Dexcom to Showcase Expanded CGM Portfolio and Industry-leading Connectivity at 82nd Scientific Sessions of the American Diabetes Association
From DexCom, Inc.
Via Business Wire
Here's How Much You Would Have Made Owning DexCom Stock In The Last 15 Years
DexCom (NASDAQ:DXCM) has outperformed the market over the past 15 years by 22.06% on an annualized basis producing an average annual return of 28.95%. Currently, DexCom has a market capitalization of... 
Via Benzinga
DexCom Dispels Rumor of Active Merger Talks as Insulet Stock Drops
"Active conversations" about a merger are not presently taking place between DexCom Inc. (DXCM), 7.28 percent, and the S&P 500 
Via Best Stocks
Dexcom Pops After Insulet Buyout Rumor Shakes Up Diabetes Stocks
The deal would have been transformative, but may have limited teamwork in the space. 
Via Investor's Business Daily
< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Daily Courier, Kelowna, BC. Powered by BLOX Content Management System from TownNews.com.